These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 7854501

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Polyuria during Guillain-Barré syndrome.
    Hantson P, De Coninck B, Horn JL, Ketelslegers JM, Mahieu P.
    Acta Neurol Belg; 1992; 92(2):77-82. PubMed ID: 1534958
    [Abstract] [Full Text] [Related]

  • 24. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome.
    Jacobs BC, van Doorn PA, Schmitz PI, Tio-Gillen AP, Herbrink P, Visser LH, Hooijkass H, van der Meché FG.
    Ann Neurol; 1996 Aug; 40(2):181-7. PubMed ID: 8773599
    [Abstract] [Full Text] [Related]

  • 25. [Guillain-Barré syndrome: from the original description to the modern concepts].
    Raphael JC, Sharshar T, Bourdain F, Léger JM.
    Ann Med Interne (Paris); 1999 Jan; 150(1):33-41. PubMed ID: 10093660
    [Abstract] [Full Text] [Related]

  • 26. [Treatment of Guillain-Barré syndrome by plasma exchange: proposal of a therapeutic strategy].
    Raphael JC, Chevret S, Jars-Guincestre MC, Chastang C, Gajdos P.
    Rev Neurol (Paris); 1996 May; 152(5):359-64. PubMed ID: 8881430
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Intravenous immune globulin in the Guillain-Barré syndrome.
    van der Meché FG.
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):43-7. PubMed ID: 8033434
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Plasmapheresis in the treatment of four cases of Guillain-Barré syndrome (acute form).
    Zerbi D, Celano I, Forlani G, Garelli S, Mosconi L, Valbonesi M.
    Ital J Neurol Sci; 1981 Dec; 2(4):331-6. PubMed ID: 7333823
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Guillain-Barré syndrome: recent advances.
    Hadden RD, Hughes RA.
    Hosp Med; 1998 Jan; 59(1):55-60. PubMed ID: 9798567
    [Abstract] [Full Text] [Related]

  • 35. Acute Guillain-Barré syndrome associated with asymptomatic HIV infection.
    Franciotta DM, Brustia R, Minoli L, Bono G, Ceroni M, Parisi A, Melzi d'Eril G.
    Acta Neurol (Napoli); 1992 Feb; 14(1):66-70. PubMed ID: 1580208
    [Abstract] [Full Text] [Related]

  • 36. The place of high dose immunoglobulins in the treatment of Guillain-Barré patients based upon the dutch trial.
    van der Meché FG.
    Wien Klin Wochenschr Suppl; 1991 Feb; 190():17-8. PubMed ID: 1771902
    [Abstract] [Full Text] [Related]

  • 37. Management of Guillain-Barré syndrome.
    Spies JM, Sheikh KA.
    Expert Rev Neurother; 2001 Sep; 1(1):119-29. PubMed ID: 19811053
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Childhood acute and chronic immune-mediated polyradiculoneuropathies.
    Rabie M, Nevo Y.
    Eur J Paediatr Neurol; 2009 May; 13(3):209-18. PubMed ID: 18585069
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.